RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

MedImmune Inc.

A collection of news and information related to MedImmune Inc. published by this site and its partners.

Top MedImmune Inc. Articles

Displaying items 13-24
  • Maryland's biotech pitch: We know the Feds

    Maryland's biotech pitch: We know the Feds
    In a conference room in downtown Baltimore, F. Blix Winston compared the Food and Drug Administration to a "slow-moving bulldog." "You don't want to get bitten," Winston, an expert on the federal regulation of medical devices, told a crowd of about 50...
  • Maryland raises $84 million to invest in tech startups

    Maryland succeeded in raising $84 million to invest in promising technology companies across the state via a novel online auction of tax credits, officials announced Thursday. The InvestMaryland plan, a cornerstone of Gov. Martin O'Malley's legislative...
  • FDA approves new flu vaccine

    FDA approves new flu vaccine
    The U.S. Food and Drug Administration has approved a new vaccine to prevent the seasonal flu. FluMist Quadrivalent is the first vaccine to contain four strains of the influenza virus - two influenza A strains and two B strains. It is manufactured by...
  • Seasonal flu vaccine may fall short

    Seasonal flu vaccine may fall short
    With all the attention given to the slow pace of distribution of the swine flu vaccine, doctors and other providers are raising concerns about a shortage of vaccine for the other flu that is expected to slam the state and country this year. Demand...
  • Some companies are healthy, producing dividends

    You might conclude that stock dividends are harder to find these days than, say, a credit card company that forgives late payments. Cash-strapped companies, most notably banks, slashed dividends last year to the tune of more than $40 billion. It was the...
  • Side deals raise ethical issues

    Executives and board members at some of Maryland's most profitable companies have lucrative side arrangements with the companies they run and oversee. Edwin F. Hale Sr., the chairman, chief executive and largest stockholder at First Mariner Bancorp,...
  • CEOs find that pay is now tied to results

    At first glance, Nolan D. Archibald might seem like a perfect example for critics of runaway executive pay. The chief executive of Black & Decker Corp. pulled in a base salary of nearly $1.5 million and a bonus of $3 million last year while...
  • FDA commissioner reassures doctors about swine flu vaccine safety

     
    Dr. Margaret A. Hamburg, commissioner of the Food and Drug Administration, sent a letter to all U.S. physicians today thanking them for their help in combating the pandemic H1N1 influenza virus and reassuring them about the safety of the vaccine......
  • FDA approves swine flu vaccine

     
    The Food and Drug Administration this morning approved the pandemic H1N1 influenza vaccine from four different manufacturers, clearing the way for the vaccine to be administered as soon as enough of it is available. The approval was announced to Congress....
  • Swine flu vaccine to start becoming available in October

     
    At least 3.4 million doses of vaccine against the pandemic H1N1 influenza virus will be available at the beginning of October, and about 20 million doses per week should become available soon after that, federal officials said today. The first......
  • Injectable vaccine better than intranasal for seasonal flu in adults

     
    Injectable vaccines containing inactivated viruses prevent about 50% more seasonal flu in healthy adults than the intranasal vaccine containing a weakened virus, according to a new report today in the New England Journal of Medicine.* "We have two...
  • H1N1 Vaccine Could Be Ready in 3 Weeks

    H1N1 Vaccine Could Be Ready in 3 Weeks
    Federal health officials said Friday that preliminary data from U.S. trials of vaccines against the pandemic H1N1 swine flu virus show that a strong immune reaction is provoked by one dose of the vaccine within 8 to 10 days after it is administered....